According to AcelRx Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -2,86ย โฌ. In 2022 the company made an earnings per share (EPS) of 5,05ย โฌ an increase over its 2021 EPS that were of -5,37ย โฌ.